Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Express Scripts
Dow
Boehringer Ingelheim
Citi
Fuji
Daiichi Sankyo
UBS
Argus Health

Generated: October 23, 2017

DrugPatentWatch Database Preview

Sun Pharm Inds Inc Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARM INDS INC, and what generic alternatives to SUN PHARM INDS INC drugs are available?

SUN PHARM INDS INC has sixty-eight approved drugs.

There are five US patents protecting SUN PHARM INDS INC drugs and there have been two Paragraph IV challenges on SUN PHARM INDS INC drugs in the past three years. There is one tentative approval on SUN PHARM INDS INC drugs.

There are ten patent family members on SUN PHARM INDS INC drugs in eight countries and seventy-one supplementary protection certificates in thirteen countries.

Summary for Applicant: Sun Pharm Inds Inc

International Patents:10
US Patents:5
Tradenames:61
Ingredients:58
NDAs:68
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET;ORAL075967-002Jan 29, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
INJECTABLE;INJECTION202126-001Aug 20, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
TABLET;ORAL076416-002Sep 29, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL090659-004Nov 6, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
PRAMIPEXOLE DIHYDROCHLORIDE
pramipexole dihydrochloride
TABLET;ORAL091683-006Mar 27, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
CARVEDILOL
carvedilol
TABLET;ORAL077346-002Sep 5, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
BENZONATATE
benzonatate
CAPSULE;ORAL040587-002Mar 19, 2008AARXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
TABLET;ORAL090118-003Dec 23, 2008AARXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
TABLET;ORAL040810-001Mar 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
ABSORICA
isotretinoin
CAPSULE;ORAL021951-006Aug 15, 2014RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Sun Pharm Inds Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Inc
EXELDERM
sulconazole nitrate
SOLUTION;TOPICAL018738-001Aug 30, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for SUN PHARM INDS INC drugs

Drugname Dosage Strength Tradename Submissiondate
isotretinoin
Capsules25 mg
ABSORICA
5/16/2016
isotretinoin
Capsules35 mg
ABSORICA
11/25/2015
isotretinoin
Capsules20 mg
ABSORICA
6/19/2013
isotretinoin
Capsules20 mg
ABSORICA
1/7/2013
isotretinoin
Capsules30 mg and 40 mg
ABSORICA
12/31/2012

International Patent Family for Sun Pharm Inds Inc Drugs

Country Document Number Estimated Expiration
European Patent Office1318791► Subscribe
Canada2423170► Subscribe
Spain2225600► Subscribe
Germany60104206► Subscribe
World Intellectual Property Organization (WIPO)0224172► Subscribe
Canada2836228► Subscribe
World Intellectual Property Organization (WIPO)2015094574► Subscribe
Australia8943801► Subscribe
Portugal1318791► Subscribe
European Patent Office2964195► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Sun Pharm Inds Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014000070Germany► SubscribePRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116
C/GB08/040United Kingdom► SubscribePRODUCT NAME: SITAGLIPTIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR THE MONOPHOSPHATE, PLUS METFORMIN OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN PARTICULAR THE HYDROCHLORIDE.; REGISTERED: CH 58450 01-03 20080408; UK EU/1/08/455/001 20080716; UK EU/1/08/455/002 20080716; UK EU/1/08/455/003 20080716; UK EU/1/08/455/004 20080716; UK EU/1/08/455/005 20080716; UK EU/1/08/455/006 20080716; UK EU/1/08/455/007 20080716; UK EU/1/08/455/008 20080716; UK EU/1/08/455/009 20080716; UK EU/1/08/455/010 20080716; UK EU/1/08/455/011 20080716; UK EU/1/08/455/012 20080716; UK EU/1/08/455/013 20080716; UK EU/1/08/455/014 20080716
00569Netherlands► SubscribePRODUCT NAME: LINAGLIPTINE, DESGEWENST IN DE VORM VAN EEN ZOUT, IN COMBINATIE MET METFORMINEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/12/780/001-028 20120720
C0002Belgium► SubscribePRODUCT NAME: REPAGLINIDE; REGISTRATION NO/DATE: EU/1/98/076/001 19980817
C/GB98/017United Kingdom► SubscribePRODUCT NAME: PRAMIPEXOLE, OPTIONALLY IN THE FORM OF AN ACID ADDITION SALT, IN PARTICULAR PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE; REGISTERED: UK EU/1/97/050/001 19971014; UK EU/1/97/050/002 19971014; UK EU/1/97/050/003 19971014; UK EU/1/97/050/004 19971014; UK EU/1/97/050/005 19971014; UK EU/1/97/050/006 19971014; UK EU/1/97/050/007 19971014; UK EU/1/97/050/008 19971014; UK EU/1/97/050/009 19971014; UK EU/1/97/050/010 19971014
2008000046Germany► SubscribePRODUCT NAME: SITAGLIPTIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE SITAGLIPTINPHOSPHAT- MONOHYDRAT, IN KOMBINATION MIT METFORMIN, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, INSBESONDERE DES HYDROCHLORIDS; NAT. REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716 FIRST REGISTRATION: CH/LI 58450 01 58450 02 58450 03 20080408
1730131/02Switzerland► SubscribePRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015
2014 00037Denmark► SubscribePRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116
C0028France► SubscribePRODUCT NAME: ASSOCIATION COMPRENANT LA SAXAGLIPTINE OU UN DE SES SELS ET LA METFORMINE OU UN DE SES SELS, Y COMPRIS L'ASSOCIATION CHLORHYDRATE DE SAXAGLIPTINE ET CHLORHYDRATE DE METFORMINE; REGISTRATION NO/DATE: EU/1/11/731/001 20111124
315Luxembourg► SubscribePRODUCT NAME: COMBINAISON COMPRENANT ALISKIREN,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE,ET AMLODIPINE,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Cipla
Mallinckrodt
UBS
Cantor Fitzgerald
Colorcon
Baxter
McKesson
US Department of Justice
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot